Diagnosis and management of von Willebrand disease in Spain

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 5, 2011, Pages 503-510

  Batlle, Javier ^a,b   Perez Rodriguez, Almudena ^a   Pinto, Joana Costa ^a   Fraga N r , Esther Loures ^a   Rodriguez Trillo Tch, Angela ^a   Fernanda Lopez Fernandez, Maria ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

diagnosis; survey; therapy; von Willebrand disease; von Willebrand factor; VWD; VWF

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; TRANEXAMIC ACID;

ARTICLE; BLEEDING TIME; DISEASE REGISTRY; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; SPAIN; THROMBOCYTE FUNCTION; VON WILLEBRAND DISEASE;

DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; HEMOSTATICS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; QUESTIONNAIRES; SPAIN; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 81755184045     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1281036     Document Type: Article

References (28)

1. Batlle J, Villar A, Liras A et al. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain. Blood Coagul Fibrinolysis 2008 19 5 333-340
2. Aznar J A., Lucia F, Abad-Franch L et al. Haemophilia in Spain. Haemophilia 2009 15 3 665-675
3. Aznar J A., Abad-Franch L, Cortina V, Marco P, Inherited Bleeding Disorders Group from the Spanish Society of Thrombosis and Haemostasis. The national registry of haemophilia A and B in Spain: results from a census of patients. Haemophilia 2009 15 1327-1353
4. Rodeghiero F, Castaman G. von Willebrand disease: epidemiology. In: Lee C A. Berntorp E E. Hoots W K. eds. Textbook of Hemophilia. Oxford, United Kingdom Blackwell 2005 265-272
5. Federici A B., Canciani M T. Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease. Haematologica 2009 94 610-615
6. Nichols W L., Hultin M B., James A H. et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008 14 2 171-232 (Pubitemid 351343618)
7. Favaloro E J. Toward a new paradigm for the identification and functional characterization of von Willebrand disease. Semin Thromb Hemost 2009 35 1 60-75
8. Sadler J E., Budde U, Eikenboom J C. et al. Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006 4 10 2103-2114 (Pubitemid 44403432)
9. Batlle J, Perez-Rodriguez A, Lopez-Fernandez M F. Classification of VWD. In: Federici A Lee C Berntorp E et al, eds. von Willebrand Disease: Basic and Clinical Aspects. Oxford, United Kingdom Blackwell 2010 74-85
10. Batlle J, Perez-Rodriguez A, Loures E, Rodriguez-Trillo A, Lopez-Fernandez M F. Metodos diagnosticos en la enfermedad de von Willebrand. LI Reunión Nacional de la AEHH; XXV Congreso Nacional de la SETH. Barcelona. Haematologica (Edición española) 2009 93 Suplemento 1 18-22
11. Penas N, Perez-Rodriguez A, Torea J H. et al. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia). Am J Hematol 2005 80 3 188-196 (Pubitemid 41579540)
12. Perez-Rodriguez A, Garcia-Rivero A, Loures E, Lopez-Fernandez M F., Rodriguez-Trillo A, Batlle J. Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications. Haematologica 2009 94 5 679-686
13. Batlle J, Perez-Rodriguez A, Franqueira M D., Lopez-Fernandez M F. Type 2M von Willebrand disease: a variant of type 2A? J Thromb Haemost 2008 6 2 388-390
14. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987 69 2 454-459 (Pubitemid 17022013)
15. Sadler J E., Mannucci P M., Berntorp E et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000 84 2 160-174 (Pubitemid 30601459)
16. Federici A B., Castaman G, Mannucci P M. Guidelines for the diagnosis and treatment of von Willebrand disease in Italy. Italian Association of Haemophilia Centers (AICE). Haemophilia 2002 8 607-611
17. Batlle J, Lopez-Fernandez M F., Fraga E L., Trillo A R., Perez-Rodriguez M A. von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Blood Coagul Fibrinolysis 2009 20 2 89-100
18. Budde U, Schneppenheim R, Eikenboom J et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost 2008 6 5 762-771 (Pubitemid 351524536)
19. Tosetto A, Rodeghiero F, Castaman G et al. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost 2007 5 4 715-721 (Pubitemid 46563569)
20. Goodeve A, Eikenboom J, Castaman G et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007 109 1 112-121 (Pubitemid 46053051)
21. Tosetto A, Rodeghiero F, Castaman G et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006 4 4 766-773
22. Rodeghiero F, Castaman G, Tosetto A et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005 3 12 2619-2626 (Pubitemid 41819788)
23. Castaman G, Lethagen S, Federici A B. et al. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood 2008 111 7 3531-3539
24. Eikenboom J, Van Marion V, Putter H et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost 2006 4 4 774-782
25. Haberichter S L., Castaman G, Budde U et al. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). Blood 2008 111 10 4979-4985
26. Castaman G, Tosetto A, Goodeve A et al. The impact of bleeding history, von Willebrand factor and PFA-100 on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD. Br J Haematol 2010 151 3 245-251
27. Castaman G, Tosetto A, Cappelletti A et al. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD. Thromb Res 2010 126 3 227-231
28. Eikenboom J, Hilbert L, Ribba A S. et al. Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. J Thromb Haemost 2009 7 8 1304-1312